Wikidata

(Q44130928)

English

Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study

scientific article published on 6 September 2014

In more languages

Statements

title
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25226868
retrieved
30 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44130928&oldid=2106913785"